763 related articles for article (PubMed ID: 29427746)
1. Nanomedicine: An effective tool in cancer therapy.
Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Nanoscale drug delivery for targeted chemotherapy.
Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
[TBL] [Abstract][Full Text] [Related]
4. Drug delivery systems using polymer nanoassemblies for cancer treatment.
Bae Y
Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
[No Abstract] [Full Text] [Related]
5. Size matters: gold nanoparticles in targeted cancer drug delivery.
Dreaden EC; Austin LA; Mackey MA; El-Sayed MA
Ther Deliv; 2012 Apr; 3(4):457-78. PubMed ID: 22834077
[TBL] [Abstract][Full Text] [Related]
6. Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system.
Kibria G; Hatakeyama H; Harashima H
Arch Pharm Res; 2014 Jan; 37(1):4-15. PubMed ID: 24272889
[TBL] [Abstract][Full Text] [Related]
7. Nano drug-delivery systems in cancer therapy: gains, pitfalls and considerations in DMPK and PD.
Elbayoumi TA
Ther Deliv; 2010 Aug; 1(2):215-9. PubMed ID: 22816128
[No Abstract] [Full Text] [Related]
8. Extracellular stability of nanoparticulate drug carriers.
Liu KC; Yeo Y
Arch Pharm Res; 2014 Jan; 37(1):16-23. PubMed ID: 24214175
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
Baksi R; Singh DP; Borse SP; Rana R; Sharma V; Nivsarkar M
Biomed Pharmacother; 2018 Oct; 106():1513-1526. PubMed ID: 30119227
[TBL] [Abstract][Full Text] [Related]
10. Carbon-based drug delivery carriers for cancer therapy.
Lim DJ; Sim M; Oh L; Lim K; Park H
Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
[TBL] [Abstract][Full Text] [Related]
11. Programmable nanomedicine: synergistic and sequential drug delivery systems.
Pacardo DB; Ligler FS; Gu Z
Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
[TBL] [Abstract][Full Text] [Related]
12. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Delivered Chemotherapy: Old Drugs in New Packages.
Lee MS; Dees EC; Wang AZ
Oncology (Williston Park); 2017 Mar; 31(3):198-208. PubMed ID: 28299757
[TBL] [Abstract][Full Text] [Related]
14. Polymeric nano-micelles: versatile platform for targeted delivery in cancer.
Mohamed S; Parayath NN; Taurin S; Greish K
Ther Deliv; 2014 Oct; 5(10):1101-21. PubMed ID: 25418269
[TBL] [Abstract][Full Text] [Related]
15. Cancer nanomedicine: from targeted delivery to combination therapy.
Xu X; Ho W; Zhang X; Bertrand N; Farokhzad O
Trends Mol Med; 2015 Apr; 21(4):223-32. PubMed ID: 25656384
[TBL] [Abstract][Full Text] [Related]
16. Gold nanoparticle (AuNP)-based drug delivery and molecular imaging for biomedical applications.
Jeong EH; Jung G; Hong CA; Lee H
Arch Pharm Res; 2014 Jan; 37(1):53-9. PubMed ID: 24214174
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
Vandghanooni S; Eskandani M; Barar J; Omidi Y
Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
[TBL] [Abstract][Full Text] [Related]
18. Promising effects of nanomedicine in cancer drug delivery.
Wakaskar RR
J Drug Target; 2018 Apr; 26(4):319-324. PubMed ID: 28875739
[TBL] [Abstract][Full Text] [Related]
19. Albumin-Based Nanodevices as Drug Carriers.
Loureiro A; Azoia NG; Gomes AC; Cavaco-Paulo A
Curr Pharm Des; 2016; 22(10):1371-90. PubMed ID: 26806342
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
